2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

 

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer
R

Fixed-Dose 7.5 mg Rasburicase Is Safe and Cost-Effective in Preventing Tumour Lysis Syndrome in Adult Haematology Patients at University College London Hospitals (UCLH) NHS Trust

By 2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer FEATURING Raakhee Shah, Rebecca Burgoyne
By 2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer FEATURING Raakhee Shah, Rebecca Burgoyne
0 views
September 11, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

01:29
Incyte

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

Young Investigator Parallel Session
09:36
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Reflections of an Experienced Investigator

Feat. J. Epstein
14:40
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Prophylactic Gabapentin in HNC

Feat. D. Smith
07:59
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Fixed-Dose 7.5 mg Rasburicase Is Safe and Cost-Effective in Preventi…

Feat. R. Shah, R. Burgoyne
09:35
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Symptoms Predictive of Overall Quality of Life Using the Edmonton Sy…

Feat. S. Chow
11:35
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Association of Frailty With Emotional Health of Older Patients With …

Feat. N. Gilmore
13:31
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Treatment-Related Mortality in Children with Acute Lymphoblastic Leu…

Feat. R. Ul-Ain